Welcome to ARUP Oncology
ARUP Laboratories’ oncology test menu offers a wide variety of testing designed to answer important clinical questions in the areas of screening, risk prediction, diagnosis, prognosis, monitoring, pharmacogenomics, and therapeutic triage of malignancies. Categorized by disease indication, the menu includes tests that utilize a large selection of methodologies, including molecular techniques, FISH, flow cytometry, and immunohistochemistry, as well as a wide variety of specimen types, including tissue, cells, and peripheral fluids. In addition, a large menu of established tumor markers, including traditional markers such as CEA, CA-125, and CA 27.29, is also available for disease monitoring.
Tests that utilize molecular techniques, including DNA sequencing, FISH, and PCR, are available to identify many tumor-specific mutations, chromosomal alterations, and gene expression. In addition, our extensive immunohistochemistry menu allows for protein-expression analysis at the cellular level. New esoteric tumor markers include alpha fetoprotein L3 percent and DCP (des-gamma-carboxy prothrombin) for hepatocellular carcinoma, CYFRA 21-1 (cytokeration 19 fragment) and SCC (squamous cell carcinoma antigen) for lung cancer, soluble mesothelian-related peptides (SMRPs) for malignant mesothelioma, inhibin B for ovarian granulosa cell tumors, and septin 9 methylated DNA for blood-based colorectal cancer screening.
For test inquiries or to arrange consultation, please contact Customer Service at (800) 522-2787 (phone) or
(800) 522-2706 (fax).
Links
- ARUP launches two FDA-approved companion diagnostic tests
- Letters of medical necessity for select disorders
